The product liability attorneys at Breslin and Breslin have recently been made aware that Nissan is recalling more than 1,800 Infiniti SUVs in the U.S. for an air bag problem that could send shrapnel into the passenger compartment.
The product liability attorneys at Breslin and Breslin would like to help spread the word about a recent recall of baby wipes. Nutek Disposables of Pennsylvania has issued a voluntary recall for its baby wipes because some packages may contain a bacteria that's often resistant to common antibiotics.
The product liability attorneys at Breslin and Breslin have just learned that the Chrysler Group is recalling Jeep and Dodge SUVs globally because their stability controls might not work, as well as their heavy-duty and commercial vehicles because their diesel-fuel heaters might get too hot.
Following a series of car accidents, General Motors is recalling more than a half-million Chevrolet Camaros because of the danger that a bump to the keys could suddenly turn off the ignition - a problem similar to the defect that led the automaker to recall millions of small cars this year. GM said that a driver's knee could jostle the key fob, causing the ignition to turn off and cutting the engine.
Please see our immediately preceding products liability blog post of this past Tuesday for relevant background information regarding the FDA's recent issuance of a proposed order aimed at manufacturers of metal-on-metal (MOM) hip implants. The instant post serves as a tandem communication on that subject and provides readers with additional information on the order and the history leading up to it.
Most people have heard recent news reports regarding a Salmonella outbreak caused by peanut butter now being sold in Trader Joe's stores throughout the nation and even right here in Bergen County. The supermarket chain has ordered a voluntary recall of the tainted peanut butter as a precautionary measure.
About two years ago, New Jersey company Johnson & Johnson made the widely-publicized decision to recall the ASR artificial hip manufactured and sold by DePuy Orthopaedics, a unit of J&J. The company set aside $3 billion to compensate people who had filed personal injury lawsuits in connection with the defective products, and seemed to acknowledge the danger of metal-on-metal artificial hips.
Last month, the U.S. Food and Drug Administration (FDA) proposed a policy which, if adopted, could significantly increase the oversight and safety of the medical device industry. Under the proposal, each individual device would receive its own identification number, allowing medical professionals and manufacturers to better track defective products, determine the cause of the problems and alert other patients who are using the same device.
Earlier this week, a unit of New Jersey-based Johnson & Johnson announced that it planned to discontinue sales of its vaginal mesh implants. The company denies that the decision was made in response to the product liability lawsuits that have been filed in connection with the mesh, but that the "negative overall publicity about vaginal mesh devices" motivated the discontinuation.
Earlier this week, we began a look at common issues with the FDA's approval process which have resulted in unsafe medical devices being approved for sale and use by patients in New Jersey and throughout the country and world. As a result, many patients who have received these medical products have reported adverse side effects including debilitating pain, injury and even death.